| Title | Publication Date | Price |
|---|---|---|
DNA Sequencing 2013Market Developments, Growth Areas and Opportunities A global market study of the DNA sequencing field, involving the participation of 233 DNA sequencers and decision-makers in more than 50 countries. | May 2013 | £1,850 |
Orphan Drug Markets in EuropeKey developments and the strategies of major pharmaceutical companies A comprehensive overview of orphan drugs in Europe and future opportunities. | November 2011 | £1,495 |
Contract Research Annual Review 2010Contract Research – a new outlook This review provides a complete picture of the market, looks at trends and developments and explains why they have happened and how they will affect the future of the market. | June 2010 | £375 |
Toxicology and PharmacologyOutsourcing, History, Process and Regulation; Technical, Political and Economic Challenges This report is essential reading for everyone involved in clinical trials and drug development including senior staff in pharmaceutical companies and CROs. | January 2010 | £995 |
Cardiac ToxicityA detailed guide to the issues surroundingcardiac toxicity and its implicationsfor the pharmaceutical market | March 2008 | £1,495 |
Orphan Drugs to 2008Understanding regulation & market opportunity in Europe Uses detailed regulatory, company and primary source information in | January 2005 | £995 |
Research & Development in the Pharmaceutical IndustryOptions for success Provides the latest information and insight into pharmaceutical industry research and development issues. Analyses the key issues affecting a pharmaceutical company's success in the search for and development of new drugs... | February 2004 | £825 |
Opportunities in Drug DeliveryIdentifying hot technologies, companies and markets Analyses the market for peptides, proteins and oligonucleotides in terms of company activities and technological developments of drug delivery companies engaged... | September 2003 | £400 |
Drug DiscoveryCurrent trends and future prospects Drug Discovery: Current Trends and Future Prospects is a major new report from Informa Global Pharmaceuticals and Healthcare reviewing over a 100 companies and their technologies relating to discovery and development. | February 2001 | £300 |